Every Form 4 that Xencor, Inc. (XNCR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow XNCR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XNCR filings page.
Xencor Inc director Ellen Feigal received new equity awards. She acquired 10,302 restricted stock units that will fully vest on the first anniversary of the June 16, 2026 grant date. She also received stock options for 20,604 shares at an exercise price of $12.20 per share, vesting in equal monthly installments over one year until June 16, 2027. Following the restricted stock grant, her directly owned common stock holdings total 22,642 shares.
Xencor Inc director Kevin Charles Gorman received new equity awards as compensation. On June 16, 2026 he was granted 10,302 restricted stock units that will fully vest on the first anniversary of the grant date.
He was also granted stock options covering 20,604 shares of common stock at an exercise price of $12.20 per share, expiring on June 15, 2036. These options vest in equal monthly installments over one year beginning one month after June 16, 2026, becoming fully vested on June 16, 2027. Following the grants, he directly holds 21,680 shares of common stock.
Xencor Inc director Kurt A. Gustafson reported equity awards rather than open-market trades. He received 10,302 shares of Common Stock as restricted stock units that will fully vest on the first anniversary of the grant date. Following this award, he directly holds 25,011 Common shares.
Gustafson also received stock options for 20,604 shares of Common Stock at an exercise price of $12.20 per share. These options vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026 and will be fully vested on June 16, 2027, with an expiration date of June 15, 2036. All transactions are coded as awards, not open-market purchases or sales.
Xencor Inc director Barbara Klencke reported equity compensation awards. She received 10,302 shares of common stock in the form of restricted stock units that will fully vest on the first anniversary of the June 16, 2026 grant. She was also granted options to buy 20,604 shares of common stock at an exercise price of $12.20 per share, vesting in equal monthly installments over one year and expiring on June 15, 2036. Following these awards, she directly holds 29,974 shares of common stock and options on 20,604 shares.
Xencor Inc director Alan Bruce Montgomery reported receiving equity compensation rather than buying shares on the market. He was granted 10,302 restricted stock units that vest fully on the first anniversary of the grant date. He also received options for 20,604 shares at an exercise price of $12.20, vesting in equal monthly installments over one year until June 16, 2027. After the RSU grant, his direct common stock holdings total 25,849 shares, and he holds 20,604 options.
Xencor Inc director Richard J. Ranieri received new equity awards as compensation. On June 16, 2026, he was granted 10,302 shares of common stock in the form of restricted stock units that will fully vest on the first anniversary of the grant date. He was also granted options to buy 20,604 shares of common stock at an exercise price of $12.20 per share, vesting in equal monthly installments over one year so that all option shares are vested by June 16, 2027. Following the grant, he directly holds 24,011 shares of common stock.
Xencor Inc director Todd E. Simpson received new equity awards as part of his compensation. On June 16, 2026, he was granted 10,302 shares of Common Stock in the form of restricted stock units, which will fully vest on the first anniversary of the grant date.
On the same date, he also received a stock option covering 20,604 shares of Common Stock at an exercise price of $12.20 per share. These option shares vest in equal monthly installments over one year beginning on the one-month anniversary of June 16, 2026, becoming fully vested on June 16, 2027. Following these awards, Simpson directly holds 23,988 shares of Common Stock and 20,604 stock options.
Deshaies Raymond Joseph reported acquisition or exercise transactions in this Form 4 filing.
Xencor Inc director Raymond Joseph Deshaies reported equity compensation grants. He received 10,302 shares of common stock in the form of restricted stock units that fully vest on the first anniversary of the June 16, 2026 grant. He was also granted options for 20,604 shares at $12.20 per share, vesting in equal monthly installments over one year and fully vesting on June 16, 2027, with expiration on June 15, 2036. Following these awards, he holds 10,302 common shares and 20,604 stock options directly.
Xencor Inc director Ellen Feigal reported an open-market sale of 6,843 shares of Common Stock at $13.06 per share. The transaction was executed on June 18, 2026 pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025. Following this sale, Feigal holds 12,340 shares directly.
Xencor Inc director Kevin Charles Gorman reported an open-market sale of 7,527 shares of Xencor common stock. The shares were sold at an average price of $12.31 per share. This trade was executed under a 10b5-1 trading plan adopted on June 27, 2025. Following the sale, Gorman directly holds 11,378 Xencor shares.
Xencor Inc director Kurt A. Gustafson reported an open-market sale of company stock. He sold 5,474 shares of Common Stock at a price of $12.31 per share. After this transaction, he directly holds 14,709 Xencor shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.
Xencor Inc director Richard J. Ranieri reported an open-market sale of company stock. On June 15, 2026, he sold 5,474 shares of Common Stock at an average price of $12.31 per share under a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025. Following this transaction, he directly holds 13,709 shares.
Xencor Inc director Alan Bruce Montgomery reported an open-market sale of Xencor common stock. On June 15, 2026, he sold 5,064 shares of Common Stock at $12.31 per share. After this transaction, he directly owned 15,547 shares of Xencor common stock.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2026, indicating the timing of the trade was set in advance rather than decided spontaneously.
Xencor Inc senior vice president and CFO Bart Jan Cornelissen reported a sale of 3,499 shares of common stock on April 10, 2026 at an average price of $12.2865 per share. According to the filing, these shares were sold to pay withholding taxes upon the vesting of 14,088 restricted stock units, making this a compensation-related, tax-driven transaction rather than a discretionary open-market sale. After this sale, Cornelissen directly owned 75,898 shares of Xencor common stock.
Xencor Inc senior executive reports tax-related share sales. SR. Vice President & CSO John R. Desjarlais sold a total of 6,620 shares of Xencor common stock in open-market transactions on March 5 and March 6. The sales were made solely to cover withholding taxes upon vesting of restricted stock units. Following these transactions, he directly holds 263,831 Xencor shares.
Xencor Inc (XNCR) senior vice president and general counsel Celia Eckert reported tax-related sales of company stock. On two days in early March, she sold a total of 5,011 shares of Xencor common stock in open-market transactions at prices around $11 per share.
The footnotes explain these were dispositions of shares sold to pay withholding taxes upon vesting of 7,316 and 4,363 restricted stock units, rather than discretionary share sales. After these transactions, she continued to hold 76,918 Xencor common shares directly.
Xencor Inc. senior vice president and CFO Bart Jan Cornelissen reported an open-market sale of 2,517 shares of common stock on March 5, 2026 at an average price of $11.2455 per share. According to the footnote, these shares were sold to pay withholding taxes upon the vesting of 7,316 restricted stock units, indicating a tax-related transaction rather than a discretionary sale. After this sale, Cornelissen directly holds 79,397 shares of Xencor common stock.
Xencor Inc President and CEO Bassil I. Dahiyat reported selling a total of 21,476 shares of common stock in early March. He sold 14,870 shares on March 5 at an average price of $11.2455 and 6,606 shares on March 6 at $11.0197. According to the footnotes, these dispositions were made to pay withholding taxes upon vesting of 36,581 and 18,179 restricted stock units. After these transactions, he directly owned 546,316 Xencor shares.
Xencor Inc. senior vice president and chief scientific officer John R. Desjarlais reported a mix of stock sales and equity awards. He sold 2,663 shares of common stock on March 3, 2026 at $11.8951 per share, with a footnote stating the sale was to pay withholding taxes on the vesting of 6,253 restricted stock units.
On March 2, 2026, he received a grant of 24,907 shares of common stock in the form of restricted stock units that vest in three equal annual installments, subject to continued service. He also received a stock option for 149,440 shares, vesting 25% one year after March 2, 2026 and the remainder monthly over the following three years, also contingent on continued service.
Xencor Inc reported that Senior Vice President and CFO Bart Jan Cornelissen received new equity awards. He was granted stock options for 116,750 shares of common stock at an exercise price of $0.00 per share, vesting over four years starting one year after March 2, 2026. He also acquired 19,458 restricted stock units that vest in three equal annual installments on the first, second, and third anniversaries of the grant date, contingent on continued service. Following these grants, he directly holds 81,914 shares of common stock.
Xencor Inc senior vice president and general counsel Celia Eckert reported new equity awards and a small tax-related share sale. She received a grant of 18,680 restricted stock units that vest in three equal annual installments, assuming she continues serving the company through each vesting date.
She was also granted options to buy 112,080 shares, with 25% vesting one year after March 2, 2026 and the rest vesting monthly so the option is fully vested after four years. On March 3, 2026, she sold 1,492 common shares at $11.8951 each to cover withholding taxes on 3,502 vested restricted stock units, and held 81,929 common shares directly afterward.
Xencor Inc President and CEO Bassil I. Dahiyat reported a mix of equity grants and a small share sale. He received a grant of 583,748 stock options and 97,291 restricted stock units, both at no cost, increasing his direct awards-based exposure to the company.
The restricted stock units vest in thirds on the first, second, and third anniversaries of the grant date, while the options vest over four years starting from March 2, 2026. Dahiyat also sold 6,758 common shares at an average price of $11.8951 per share to pay withholding taxes related to the vesting of 17,507 restricted stock units, and directly held 567,792 common shares after the sale.
Xencor Inc. senior vice president and chief scientific officer John R. Desjarlais exercised a stock option for 5,322 shares of common stock on January 23, 2026. The option had an exercise price of $12.51 per share and had fully vested under a schedule beginning January 26, 2016. Following the exercise, Desjarlais directly owned 248,207 shares of Xencor common stock. The derivative position reported as a stock option now shows zero options remaining, reflecting the exercise of this expiring grant and no reported sale of the underlying shares.